Pinnacle Financial Group, Inc.’s Aclaris Therapeutics ACRS Stock Holding History
Bought
Maintained
Sold
Other funds holding ACRS
BCM
Pinnacle Financial Group, Inc.'s ACRS Position: Q3 2026 in Review
Pinnacle Financial Group, Inc. opened a new position in Aclaris Therapeutics (ACRS) in Q3 2026: 650 shares worth $3.42K. The stake represents ﹤0.01% of the portfolio and ranks #1890 among its holdings.
166 funds tracked by Wall St. Rank hold ACRS as of Q3 2026.
- Pinnacle Financial Group, Inc. held 650 shares of Aclaris Therapeutics worth $3.42K as of Q3 2026.
- Aclaris Therapeutics was a new Pinnacle Financial Group, Inc. position in Q3 2026.
- Aclaris Therapeutics made up ﹤0.01% of Pinnacle Financial Group, Inc.'s portfolio in Q3 2026, its #1890 holding.
- 166 funds tracked by Wall St. Rank held Aclaris Therapeutics as of Q3 2026.
Based on Pinnacle Financial Group, Inc.'s 13F filing for Q3 2026, filed 16 Nov 2026.